Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00037193 · ClinicalTrials.gov registry record
Acute Regulation of Parathyroid Hormone by Dietary Phosphate
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00037193: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00037193 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00037193 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
Patients with end stage renal disease often have secondary hyperparathyroidism due to high phosphorus and low calcium levels in the blood. Preliminary animal studies and our initial human study indicate that the parathyroid hormone levels may change quickly based on the ingestion of phosphorus, prior to any change in the blood levels of calcium or phosphorus. This follow-up study will attempt to determine if the effect is independent of an increase in the blood glucose level. If so, this would suggest an as yet unidentified gastrointestinal receptor that mediates parathyroid hormone levels. This may affect the timing of administration and the type of phosphate binder used in treating patients with secondary hyperparathyroidism. The knowledge that parathyroid hormone levels can change acutely may also affect the recommended timing of blood samples
Trial Details
| Field | Value |
|---|
What the finished NCT00037193 record still lists
NCT00037193 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00037193 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00037193 about?
NCT00037193 is a clinical study titled "Acute Regulation of Parathyroid Hormone by Dietary Phosphate". Patients with end stage renal disease often have secondary hyperparathyroidism due to high phosphorus and low calcium levels in the blood. Preliminary animal studies and our initial human study indicate that the parathyroid hormone levels may change quickly based on the ingestion of phosphorus, prio...
What is the current status of trial NCT00037193?
This trial is currently completed.
Who is sponsoring clinical trial NCT00037193?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.